Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ConvaTec Group's share price for the quarter that ended in Dec. 2023 was £2.442. ConvaTec Group's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,050 Mil. Therefore, ConvaTec Group's market cap for the quarter that ended in Dec. 2023 was £5,006 Mil.
ConvaTec Group's quarterly market cap
declined
from Dec. 2022 (£4,754 Mil) to Jun. 2023 (£4,198 Mil) but then
increased
from Jun. 2023 (£4,198 Mil) to Dec. 2023 (£5,006 Mil).
ConvaTec Group's annual market cap
increased
from Dec. 2021 (£3,891 Mil) to Dec. 2022 (£4,754 Mil) and
increased
from Dec. 2022 (£4,754 Mil) to Dec. 2023 (£5,006 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ConvaTec Group's Enterprise Value for Today is £6,422 Mil.
ConvaTec Group Market Cap Historical Data
The historical data trend for ConvaTec Group's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ConvaTec Group's Market Cap
For the Medical Instruments & Supplies subindustry, ConvaTec Group's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ConvaTec Group's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's Market Cap distribution charts can be found below:
* The bar in red indicates where ConvaTec Group's Market Cap falls into.
ConvaTec Group Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ConvaTec Group's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ConvaTec Group (LSE:CTEC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ConvaTec Group Market Cap Related Terms
Thank you for viewing the detailed overview of ConvaTec Group's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
LSE:CTEC has been successfully added to your 